Hubei Xunda Pharmaceutical

Hubei Xunda Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and finished drug products. Established in 1970 and headquartered in Wuxue, Hubei, the company has become one of the world's largest producers of non-steroidal anti-inflammatory drugs (NSAIDs), including Ibuprofen and Naproxen. Their operations are supported by multiple GMP-certified production lines and a robust quality management system that meets international standards such as US FDA and EU GMP. Hubei Xunda exports its products to over 50 countries, serving as a critical supplier in the global pharmaceutical supply chain. In addition to its core NSAID portfolio, the company produces a range of cardiovascular, gastrointestinal, and anti-infective medications. The company maintains a strong focus on technical innovation and environmental sustainability within its manufacturing processes.